|
1
|
The role of DNA mismatch repair in platinum drug resistance.
|
Cancer Res
|
1996
|
2.88
|
|
2
|
The role of DNA mismatch repair in drug resistance.
|
Clin Cancer Res
|
1998
|
2.49
|
|
3
|
Loss of DNA mismatch repair: effects on the rate of mutation to drug resistance.
|
J Natl Cancer Inst
|
1997
|
1.58
|
|
4
|
The Notch pathway in ovarian carcinomas and adenomas.
|
Br J Cancer
|
2005
|
1.54
|
|
5
|
In vitro and in vivo resistance to cisplatin in cells that have lost DNA mismatch repair.
|
Cancer Res
|
1997
|
1.50
|
|
6
|
Differential induction of c-Jun NH2-terminal kinase and c-Abl kinase in DNA mismatch repair-proficient and -deficient cells exposed to cisplatin.
|
Cancer Res
|
1997
|
1.29
|
|
7
|
Biochemical characterization of the human arsenite-stimulated ATPase (hASNA-I).
|
J Biol Chem
|
1998
|
1.03
|
|
8
|
The effect of different chemotherapeutic agents on the enrichment of DNA mismatch repair-deficient tumour cells.
|
Br J Cancer
|
1998
|
1.00
|
|
9
|
CA15-3 and alkaline phosphatase as predictors for breast cancer recurrence: a combined analysis of seven International Breast Cancer Study Group trials.
|
Ann Oncol
|
2007
|
0.94
|
|
10
|
Success and relapse rate after treatment of cryptorchidism with intranasal LHRH.
|
Acta Paediatr Scand
|
1985
|
0.94
|
|
11
|
Bcl-x(L) antisense oligonucleotides induce apoptosis and increase sensitivity of pancreatic cancer cells to gemcitabine.
|
Int J Cancer
|
2001
|
0.94
|
|
12
|
Molecular characteristics of Haemophilus influenzae causing invasive disease during the period of vaccination in Switzerland: analysis of strains isolated between 1986 and 1993.
|
J Clin Microbiol
|
1996
|
0.93
|
|
13
|
Comparative genomic hybridization analysis of chromosomal changes occurring during development of acquired resistance to cisplatin in human ovarian carcinoma cells.
|
Genes Chromosomes Cancer
|
1997
|
0.92
|
|
14
|
Expression of the DNA mismatch repair proteins hMLH1 and hPMS2 in normal human tissues.
|
Br J Cancer
|
1997
|
0.91
|
|
15
|
A randomized crossover trial assessing patient preference for two different types of portable infusion-pump devices.
|
Ann Oncol
|
1999
|
0.91
|
|
16
|
Isolation of the ATP-binding human homolog of the arsA component of the bacterial arsenite transporter.
|
Genomics
|
1996
|
0.90
|
|
17
|
Overexpression of the p73 gene is a novel finding in high-risk B-cell chronic lymphocytic leukemia.
|
Ann Oncol
|
2001
|
0.89
|
|
18
|
Loss of DNA mismatch repair due to knockout of MSH2 or PMS2 results in resistance to cisplatin and carboplatin.
|
Int J Oncol
|
1997
|
0.87
|
|
19
|
The enigma of young age.
|
Ann Oncol
|
2006
|
0.86
|
|
20
|
Bone mineral density in breast cancer patients treated with adjuvant letrozole, tamoxifen, or sequences of letrozole and tamoxifen in the BIG 1-98 study (SAKK 21/07).
|
Ann Oncol
|
2011
|
0.85
|
|
21
|
L-2-oxothiazolidine-4-carboxylic acid, a cysteine prodrug: pharmacokinetics and effects on thiols in plasma and lymphocytes in human.
|
J Pharmacol Exp Ther
|
1991
|
0.84
|
|
22
|
The effect of endocrine responsiveness on high-risk breast cancer treated with dose-intensive chemotherapy: results of International Breast Cancer Study Group Trial 15-95 after prolonged follow-up.
|
Ann Oncol
|
2009
|
0.84
|
|
23
|
Differential expression of p73 splice variants and protein in benign and malignant ovarian tumours.
|
Int J Cancer
|
2000
|
0.83
|
|
24
|
Loss of DNA mismatch repair facilitates reactivation of a reporter plasmid damaged by cisplatin.
|
Br J Cancer
|
1999
|
0.82
|
|
25
|
Retinoid receptors in ovarian cancer: expression and prognosis.
|
Ann Oncol
|
2005
|
0.81
|
|
26
|
PRO_10--a new tissue-based prognostic multigene marker in patients with early estrogen receptor-positive breast cancer.
|
Pathobiology
|
2011
|
0.80
|
|
27
|
Epidermal growth factor enhances cisplatin-induced apoptosis by a caspase 3 independent pathway.
|
Cancer Chemother Pharmacol
|
2001
|
0.80
|
|
28
|
Activity of gemcitabine and continuous infusion fluorouracil in advanced pancreatic cancer.
|
Oncology
|
2001
|
0.79
|
|
29
|
Increase in tumor GADD153 mRNA level following treatment correlates with response to paclitaxel.
|
Cancer Chemother Pharmacol
|
2000
|
0.79
|
|
30
|
Capecitabine and vinorelbine in elderly patients (> or =65 years) with metastatic breast cancer: a phase I trial (SAKK 25/99).
|
Ann Oncol
|
2004
|
0.79
|
|
31
|
Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancer.
|
Br J Cancer
|
2007
|
0.78
|
|
32
|
Ovarian cancer. an institutional review of patterns of care, health insurance and prognosis.
|
Eur J Cancer
|
2000
|
0.78
|
|
33
|
Activity of raltitrexed and gemcitabine in advanced pancreatic cancer.
|
Ann Oncol
|
2003
|
0.77
|
|
34
|
Analgesic action of i.v. morphine-6-glucuronide in healthy volunteers.
|
Br J Anaesth
|
2000
|
0.77
|
|
35
|
High-dose chemotherapy for ovarian cancer: are we ready to go?
|
Ann Oncol
|
2001
|
0.75
|
|
36
|
Reply to 'Staging for distant metastases in operable breast cancer: a suggested expansion of the ESMO guideline recommendation for staging imaging of node-negative, hormonal receptor-negative disease' by U. Gueth et al.
|
Ann Oncol
|
2013
|
0.75
|
|
37
|
Endometrial cancer: a frequent orphan disease.
|
Ann Oncol
|
2004
|
0.75
|
|
38
|
Brain metastases in gastro-oesophageal adenocarcinoma: insights into the role of the human epidermal growth factor receptor 2 (HER2).
|
Br J Cancer
|
2015
|
0.75
|
|
39
|
[Aromatase inhibitors in the adjuvant therapy of breast carcinomas].
|
Ther Umsch
|
2004
|
0.75
|
|
40
|
[Status of radiologic pelvimetry].
|
Geburtshilfe Frauenheilkd
|
1987
|
0.75
|
|
41
|
Determination of 5-fluorouracil and 5-fluoro-2'-deoxyuridine-5'-monophosphate in pancreatic cancer cell line and other biological materials using capillary electrophoresis.
|
J Chromatogr A
|
2001
|
0.75
|
|
42
|
Divergent expression of cyclin-dependent kinase inhibitors (CKI) and p14ARF/p16 beta in non-Hodgkin's lymphomas and chronic lymphocytic leukemia.
|
Leuk Lymphoma
|
2000
|
0.75
|
|
43
|
[Sentinel lymphadenectomy: an alternative to axillary lymphadenectomy in breast carcinoma].
|
Schweiz Med Wochenschr
|
1998
|
0.75
|
|
44
|
[Effectiveness of specialized nursing for patients with breast cancer and other gynecologic cancers: a prospective, longitudinal, two-arm pilot study in Switzerland].
|
Pflege
|
2008
|
0.75
|
|
45
|
In vitro antineoplastic activity of a novel lanthionine-containing peptide.
|
Clin Cancer Res
|
1997
|
0.75
|